280 related articles for article (PubMed ID: 31620361)
1. Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.
Yang B; Shen J; Xu L; Chen Y; Che X; Qu X; Liu Y; Teng Y; Li Z
Front Oncol; 2019; 9():898. PubMed ID: 31620361
[No Abstract] [Full Text] [Related]
2. Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma.
Ji Y; Xue Y
Onco Targets Ther; 2020; 13():8395-8411. PubMed ID: 32904613
[TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
4. Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis.
Lu R; Li Z; Yin S
Biochem Genet; 2022 Oct; 60(5):1825-1844. PubMed ID: 35098409
[TBL] [Abstract][Full Text] [Related]
5. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
6. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
7. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes.
Feng C; Liu S; Shang Z
Front Cell Dev Biol; 2021; 9():798898. PubMed ID: 35273966
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
10. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
11. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
[TBL] [Abstract][Full Text] [Related]
12. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Diao P; Song Y; Ge H; Wu Y; Li J; Zhang W; Wang Y; Cheng J
J Cell Biochem; 2019 Jun; 120(6):10010-10020. PubMed ID: 30548328
[TBL] [Abstract][Full Text] [Related]
13. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
[No Abstract] [Full Text] [Related]
14. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
15. Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Zhang B; Wang H; Guo Z; Zhang X
J Cell Physiol; 2019 Aug; 234(10):18781-18791. PubMed ID: 30927266
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
Jing L; Du Y; Fu D
Front Genet; 2022; 13():979575. PubMed ID: 36105083
[TBL] [Abstract][Full Text] [Related]
17. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Li J; Li Y; Wu X; Li Y
Oncol Lett; 2019 Jun; 17(6):5642-5652. PubMed ID: 31186787
[TBL] [Abstract][Full Text] [Related]
19. Identification of autophagy-related gene and lncRNA signatures in the prognosis of HNSCC.
Li Q; Wang J; Meng X; Chen W; Feng J; Mao J
Oral Dis; 2023 Jan; 29(1):138-153. PubMed ID: 33901303
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
